BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 15, 2005
View Archived Issues
Update on the antiarrhythmic properties of ZP-123
Read More
Novel orally active PI3Kgamma inhibitor effective in various models of inflammation
Read More
Dual HER1/HER2 inhibitor disclosed by BMS scientists
Read More
Hippocampal neurogenesis contributes to antidepressant action of SSR-125543A
Read More
In vivo studies show efficacy for LY-379268 in opiate relapse
Read More
Preliminary phase I data on GCS-100 in advanced solid tumors
Read More
BAL-8557 reported as effective as fluconazole in esophageal candidiasis
Read More
New data on the metabolic effects of SOM-230 in patients with acromegaly
Read More
Novel agents imparted for the treatment of obesity and lipoprotein disorders
Read More
Recent patents disclose therapeutic agents for gastrointestinal disorders
Read More
Alcon patents superoxide dismutase mimics for optic nerve and retinal damage
Read More
Phase Ib study investigates PXD-101 for advanced solid tumors
Read More
L-Lysine-D-amphetamine: Prodrug of D-amphetamine in clinical development
Read More
Biovitrum advances BVT-28949 into clinical testing for glaucoma
Read More
Novel glucagon inhibitor shows promise for type 2 diabetes
Read More
Arrow cleared to add U.S. sites to phase IIa study of A-60444 for RSV
Read More
Amarin reaches SPA agreement for phase III trials of Miraxion
Read More
Pharmacokinetics results for NRP-290 for pain
Read More
NIDA grant supports development of NicVAX
Read More
FDA removes clinical hold on PRTX-100
Read More
Vical grants options to Merck for cancer vaccines
Read More
Alvimopan enters phase III program for opioid-induced constipation
Read More
E1-I.N.T. studied in type 2 diabetes patients
Read More
Efficacy and potential impact of rotavirus vaccine explored
Read More
Study finds motavizumab safe, active in infants with respiratory syncytial virus
Read More
Arranon recommended for accelerated FDA approval
Read More
Sorafenib NDA granted priority review status
Read More
ODAC recommends approval of Revlimid
Read More
Dabigatran results encourage phase III investigation in atrial fibrillation patients
Read More